Definium announced positive topline results from the Emerge Phase 3 study, with DT120 ODT demonstrating an 8.1-point placebo-adjusted improvement on t...
Financial News Archive
SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
Worksport Ltd announced record 35% gross margin in May 2026, up 660 basis points from Q1, and secured Meyer Distributing as a national distribution pa...
Olenox Industries amended its membership interest purchase agreement to acquire CS Digital Ventures LLC from multiple members, with Bernardo Schucman ...
Rayonier Advanced Materials appointed Daniel M. Krawczyk as Chief Executive Officer and President effective immediately. The appointment supports the ...
Tutor Perini Corporation announced a private offering of $400 million in senior notes due 2033, with proceeds to redeem existing 11.875% notes due 202...
AbbVie Inc. has entered into a definitive merger agreement to acquire Apogee Therapeutics, Inc. through a subsidiary merger structure. The transaction...
First Citizens Community Bank amended its Supplemental Executive Retirement Plan effective June 16, 2026, modifying benefit structures for participati...
Apogee Therapeutics signed an Antibody Discovery Agreement with Paragon Therapeutics effective June 17, 2026, for discovery and development of monospe...
CRH Americas and Neon Merger Sub have entered into an Agreement and Plan of Merger to acquire Arcosa Inc., effective June 21, 2026. The transaction co...
Ligand Pharmaceuticals entered into a fourth amendment to its credit agreement with Citibank as administrative agent, consenting to the issuance of up...
AbbVie announced a definitive agreement to acquire Apogee Therapeutics for $135.11 per share, totaling approximately $10.9 billion in equity value. Th...
TMCC's consolidated net income increased to $2.3 billion in fiscal 2026 from $1.7 billion in fiscal 2025, driven by lower interest expenses and higher...
TScan Therapeutics announced positive initial data from Cohort C of the ALLOHA Phase 1 study, with 11 of 14 patients achieving complete donor chimeris...
MapLight Therapeutics announced topline data from its Phase 2 IRIS trial evaluating ML-004 for autism spectrum disorder treatment. The clinical trial ...
HawkEye 360 achieved record Q1 2026 revenue of $49.8 million with 116.5% year-over-year growth and a $285 million backlog, while completing an IPO tha...
EyePoint's board approved Amendment No. 3 to its 2023 Long-Term Incentive Plan, increasing the maximum shares available for equity awards to 15.3 mill...
Fervo Energy completed a $2.2 billion IPO in May 2026 and reported a Q1 net loss of $31.8 million while advancing its Cape Station geothermal project ...
CRH Americas, Inc. has entered into a definitive merger agreement to acquire Arcosa, Inc. through a merger with Neon Merger Sub, Inc. The transaction ...
MoonLake's sonelokimab achieved 67% HiSCR75 response rate and 26% inflammatory remission at Week 52 in hidradenitis suppurativa trials, with BLA submi...
Traws Pharma announced it will resubmit an updated toxicology data package for tivoxavir marboxil to the UK's MHRA in Q3 2026 to advance a Phase 2a hu...